Tatva Chintan Pharma Chem Operational Benchmarking
₹1,792.80-3.38%close, 9 Oct 2026
- Market cap
- ₹4,194 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹1,290.82 – ₹2,420.28
Tatva Chintan Pharma Chem compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Tatva Chintan Pharma Chem sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Tatva Chintan Pharma Chem Limited | ₹1,792.80 | 22.5 | 4,194 | 1.2% | 1,048 | 14.5% |
| Median (1 Cos) | ₹1,792.80 | 22.5 | 4,194 | 1.2% | 1,048 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Themis Medicare Limited operational benchmarking
- Syngene International Limited operational benchmarking
- Thyrocare Technologies Limited operational benchmarking
- Syncom Formulations (India) Limited operational benchmarking
- Torrent Pharmaceuticals Limited operational benchmarking
- Suven Life Sciences Limited operational benchmarking
Trade Tatva Chintan Pharma Chem With ATS
Track TATVA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.